A phase II study of concomitant boost radiation plus concurrent weekly cisplatin for locally advanced unresectable head and neck carcinomas
- 30 April 2006
- journal article
- research article
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 79 (1), 34-38
- https://doi.org/10.1016/j.radonc.2006.03.010
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Hyperfractionated accelerated radiotherapy in combination with weekly cisplatin for locally advanced head and neck cancerHead & Neck, 2004
- Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6&7 randomised controlled trialThe Lancet, 2003
- Altered fractionation and combined radio-chemotherapy approachesEuropean Journal Of Cancer, 2003
- An Intergroup Phase III Comparison of Standard Radiation Therapy and Two Schedules of Concurrent Chemoradiotherapy in Patients With Unresectable Squamous Cell Head and Neck CancerJournal of Clinical Oncology, 2003
- A radiation therapy oncology group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003International Journal of Radiation Oncology*Biology*Physics, 2000
- Simultaneous radiochemotherapy versus radiotherapy alone in advanced head and neck cancer: a randomized multicenter study.Journal of Clinical Oncology, 1998
- Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma: final analysis of a randomized trial of the EORTC cooperative group of radiotherapyRadiotherapy and Oncology, 1992
- Prospective randomized trial comparing hyperfractionated versus conventional radiotherapy in stages III and IV oropharyngeal carcinomaInternational Journal of Radiation Oncology*Biology*Physics, 1991
- Concomitant cisplatin chemotherapy and radiotherapy in advanced mucosal squamous cell carcinoma of the head and neck. Long-term results of the radiation therapy oncology group study 81-17Cancer, 1990
- Improved response and survival to combined cisplatin and radiation in non-keratinizing squamous cell carcinomas of the head and neck. An RTOG study of 114 advanced stage tumorsCancer, 1987